Health Ca ada authorizes DAYVIGO (lemborexa t) for treatme t of i som ia — MISSISSAUGA, ON, Feb. 4, 2021 – Eisai Limited, the Ca adia subsidiary of Eisai I c., today a ou ced the Ca adia authorizatio a d availability of a ew o -sedative prescriptio medicatio , DAYVIGO™ (lemborexa t). Available i both 5 mg a d [...]